. 2017 Sep 21;8(54):91990–92003. doi: 10.18632/oncotarget.21121

Table 1. The IC50 values (μM) of various chemotherapeutic agents on cell viability in breast cancer cell lines.

Cells	Doxorubicin	Pirarubicin	Epirubicin	Paclitaxel	CDDP
MCF-7/Con1600	1.81 ± 0.45	0.50 ± 0.08	10.00 ± 0.42	1.95 ± 0.56	7.98 ± 3.86
MCF-7/Dox1600	270.00 ± 46.00^*	19.19 ± 7.58^*	228.24 ± 127.66^*	294.23 ± 178.02^*	21.76 ± 4.89^*
MCF-7/Dox/NC	302 ± 87.91^*	20.90 ± 2.31^*	175.55 ± 105.25^*	278.01 ± 46.43^*	18.66 ± 6.06^*
MCF-7/Dox/shH19	26.32 ± 1.81^{#^*&}	3.44 ± 1.63^{#^*&}	32.65 ± 7.54^{#^*&}	9.38 ± 3.36^{#^*&}	19.38 ± 4.65^*

^*p < 0.05 compared to MCF-7/Con1600 group; ^#p < 0.05 compared to MCF-7/Dox/NC group; ^&p < 0.05 compared to MCF-7/Dox1600 group.